相关实验视频

Updated: Jul 14, 2025

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

眼部神经血管疾病中的circRNA:基本机制和临床潜力

Wenxin Zhang¹, Yuxi He¹, Yan Zhang²

¹Department of Ophthalmology, 2nd Hospital of Jilin University, Changchun 130041, Jilin, China.

Pharmacological research

|October 5, 2023

概括

循环RNAs (circRNAs) 显示出对治疗眼部新血管疾病 (ONDs) 的承诺. 这篇评论探讨了circRNAs.

科学领域:

眼科医生眼科眼科
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

眼神血管疾病 (OND) 由于血管生长异常,导致明显的视力损伤和失明.
循环RNAs (circRNAs),非编码RNAs,越来越多地被认为是它们在生物过程中的作用,包括血管生成.
它们与OND的关联使它们成为诊断和治疗的关键研究重点.

研究的目的:

审查circRNAs在ONDs管理中的潜力.
阐明circRNAs在血管生成的五个阶段中的调节作用.
分析特定OND中的circRNA相互作用及其诊断潜力.

主要方法:

文献审查侧重于circRNAs和ONDs.
在血管生成中分析circRNA调节.
详细检查皮质细胞中circRNAs,角膜新血管化,与年龄相关的黄斑变性,糖尿病视网膜病变和早产视网膜病变.

主要成果:

循环RNA在血管生成中起着调节作用,提供潜在的治疗点.
特定的circRNA涉及到各种OND,表明它们与疾病的关联.
循环RNA显示出作为OND诊断生物标志物的潜力.

结论:

循环RNAs 代表了对 OND 管理策略的一个有前途的途径.
需要进一步的研究来弥合当前发现和临床应用之间的差距.
利用circRNAs可能会导致对视力威胁疾病的新型诊断和治疗方法.

关键词:

血管新生的产生.生物标志物生物标志物这是循环RNARNA.这是一种MiRNA海绵.新血管化的新血管化.眼部新血管疾病是什么?

更多相关视频

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model

Published on: January 21, 2018

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

相关概念视频

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...